Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Abstract. Background: So far, planning of clinical trials in multiple myeloma (MM) has been based on traditional outcome measures such as progression free (PFS)

  • 123456 Profile photo of Madelyn

    We like to assume what patients want- but a substantial minority prefer PFS over QOL in the maintenance setting. Very thought provoking.